Revenue of $227.1 million, up 13% year-over-year. Calculated current billings of $248.4 million, up 11% year-over-year. GAAP operating margin of (1)%; Non-GAAP operating margin of 20%. Net cash provided by operating activities of $54.6 million; Unlevered …
HAMILTON, Bermuda, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Teekay Tankers Ltd. (Teekay Tankers or the Company) (NYSE: TNK) today reported the Company's results for the quarter ended September 30, 2024 and announced that its Board of Directors has declared a …
The UK’s National Quantum Computing Centre (NQCC) officially opened the doors of its landmark facility on Harwell Campus on October 25. The state-of-the-art facility includes a fully operational 24-qubit Ankaa™-class Rigetti system, which will be made …
HOUSTON, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Orion Group Holdings, Inc. (NYSE: ORN) (the “Company”), a leading specialty construction company, today reported its financial results for the third quarter ended September 30, 2024. Highlights for the quarter …
Highlights: GAAP diluted earnings per share (EPS) of $0.39 and revenue of $1.0 billion for the third quarter Non-GAAP adjusted EPS of $0.52, which excludes adjustments for a network alignment initiative and transaction related expenses in the quarter …
NEW YORK, Oct. 30, 2024 (GLOBE NEWSWIRE) -- New York Mortgage Trust, Inc. (Nasdaq: NYMT) (“NYMT,” the “Company,” “we,” “our” or “us”) today reported results for the three and nine months ended September 30, 2024. Summary of Third Quarter 2024: (dollar …
CAMBRIDGE, Mass., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, will …
REDWOOD CITY, Calif., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced that it will report financial results …
WILMINGTON, Del. – Today, Delaware Governor John Carney, U.S. Senators Tom Carper and Chris Coons and U.S. Representative Lisa Blunt Rochester (all D-Del.) announced $127.5 million for Port Wilmington as part of the U.S. Environmental Protection Agency’s ( …
HOUSTON, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Archrock, Inc. (NYSE:AROC) (“Archrock”) will host a conference call on Tuesday, November 12, 2024, to discuss its third quarter 2024 financial and operating results. The call will begin at 9:00 a.m. Eastern Time. …
PEKIN, Ill., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO), a leading producer and distributor of specialty alcohols, renewable fuels and essential ingredients, announced it will release its third quarter 2024 financial results …
HAMILTON, Bermuda, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Teekay Corporation Ltd. (Teekay or the Company) (NYSE:TK) today reported results for the three months ended September 30, 2024. The full earnings release and Teekay Group’s earnings presentation are …
SAN JOSE, Calif., Oct. 30, 2024 (GLOBE NEWSWIRE) -- At its meeting on October 30, 2024, the California Water Service Group (NYSE: CWT) Board of Directors declared the company's 319th consecutive quarterly dividend in the amount of $0.28 per common …
SANTA ANA, Calif., Oct. 30, 2024 (GLOBE NEWSWIRE) -- TTM Technologies, Inc. (NASDAQ: TTMI) (“TTM”), a leading global manufacturer of technology solutions including mission systems, radio frequency (“RF”) components and RF microwave/microelectronic …
SOUTH SAN FRANCISCO, Calif., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), Aligos a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, …
AUSTIN, Texas, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Lumos Pharma (NASDAQ:LUMO), a clinical stage biopharmaceutical company focused on therapeutics for rare diseases, announced today that updated analyses of data from the Company’s Phase 2 OraGrowtH210 and …
FREMONT, Calif., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the following investor conferences in November. Guggenheim Inaugural …
COVINGTON, La., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Pool Corporation (Nasdaq/GSM:POOL) announced today that its Board of Directors declared a quarterly cash dividend of $1.20 per share. The dividend will be payable on November 27, 2024, to holders of record …
-- Strong Cash Position of $306 Million; 9th Consecutive Quarter of Positive or Neutral Cash Balance -- -- Total Net Revenue of $42 Million Represents Continued Source of Cash from the U.S., RoW Partnerships and Early Phases of European Launches -- -- …
Q1 2025 Recurring & Other Revenue of $333.1 million, up 14% year-over-year Q1 2025 Total Revenue of $363.0 million, up 14% year-over-year Acquisition of Airbase, a modern finance and spend management software solution, completed on October 1, 2024 …
